Summary & Overview
CPT 98984: Remote Therapeutic Monitoring—Respiratory Devices (2–15 Days)
CPT code 98984 designates the supply of one or more devices for remote therapeutic monitoring (RTM) of the respiratory system for monitoring that occurs two to 15 days within a 30‑day period. This code is part of the growing set of RTM services that enable clinicians to manage respiratory function and therapy adherence remotely using device‑derived data. Nationally, adoption of RTM codes affects care models for chronic respiratory conditions, telehealth integration, and payer coverage policies.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical intent and service setting, plus benchmarking and policy context where available. The publication outlines common payer coverage patterns and reimbursement considerations, summarizes clinical use cases for short‑interval device monitoring (two to 15 days per 30‑day period), and identifies related billing and coding topics for operational teams.
This summary is intended for billing managers, clinicians implementing RTM programs, and policy analysts seeking a national perspective on RTM respiratory device supply and short‑interval monitoring services.
Billing Code Overview
CPT code 98984 describes the provision of one or more devices used for remote therapeutic monitoring (RTM) of the respiratory system when monitoring occurs for two to 15 days within a 30‑day period. The service focuses on therapeutic device‑based physiological monitoring rather than diagnostic testing or in‑person treatment.
Service type: Remote Therapeutic Monitoring — Respiratory
Typical site of service: Home or other non‑face‑to‑face outpatient settings where the patient uses RTM devices and data are transmitted to the billing provider for therapeutic monitoring and management.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with moderate chronic obstructive pulmonary disease (COPD) is discharged from an outpatient pulmonary clinic after an exacerbation requiring outpatient follow-up. The provider supplies an FDA-cleared remote therapeutic monitoring (RTM) device that measures respiratory parameters (such as respiratory rate, inhaler usage, or thoracic impedance-derived metrics) and configures the system for home monitoring. The monitoring plan is set for 10 nonconsecutive days of active data collection within a 30-day period. The clinical workflow includes device setup and patient education during the clinic visit, device shipping and activation, remote data review by the clinician or designated clinical staff, adjustment of therapy or follow-up telemedicine visits based on transmitted data, and documentation of device supply and monitoring interval.
Typical site of service is an outpatient clinic, ambulatory surgery center, or hospital outpatient department where the device is provided and patient instruction occurs. The patient scenario commonly involves chronic respiratory disease management such as COPD, asthma with poor control, or other chronic respiratory insufficiency requiring short-interval therapeutic monitoring to assess response to treatment or medication adherence.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
59 | Distinct procedural service | When a separate, distinct RTM supply/service is furnished on the same date as another procedure and documentation supports distinctness. |